Adjuvant simultaneous radiochemotherapy following radical hysterectomy for patients with cervical cancers in high-risk situation - Results of a pilot study;Adjuvante simultane radiochemotherapie nach operiertem uteruszervixkarzinom in der high-risk-situation. Ergebnisse einer pilotuntersuchung

Strahlentherapie und Onkologie

Volumn 178, Issue 2, 2002, Pages 71-77

  Hänsgen, Gabriele ^a   Kuhnt, Thomas ^a   Pigorsch, Steffi ^a   Strauss, Hans ^b   Dunst, Jürgen ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b Klinik für Gynäkologie der Martin Luther Universität   (Germany)

Author keywords

Adjuvant chemoradiation; Cervical cancer

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; ARTICLE; BEAM THERAPY; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG INDUCED DISEASE; FEMALE; HIGH RISK PATIENT; HUMAN; LEUKOPENIA; LYMPH NODE METASTASIS; LYMPHEDEMA; PARAAORTIC LYMPH NODE; PILOT STUDY; PROGNOSIS; RADIATION DOSE; RADIATION INJURY; RADICAL HYSTERECTOMY; SURGICAL TECHNIQUE; UTERINE CERVIX CARCINOMA;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CISPLATIN; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MIDDLE AGED; PILOT PROJECTS; RADIOTHERAPY, ADJUVANT; SURVIVAL RATE; UTERINE CERVICAL NEOPLASMS;

EID: 0036169874     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-002-0914-y     Document Type: Article

References (32)

1. Clinical presentation and management of stage I cervical adenocarcinoma: A 25 year experience
2. Die adjuvante chemotherapie des zervixkarzinoms - Ergebnisse einer phase-II-studie
3. Randomized trial of neoadjuvant cisplatin, vincristine, bleomycin, and radical hysterectomy versus radiation therapy for bulky stage IB and IIA cervical cancer
4. Adjuvant radiotherapy after radical hysterectomy of the cervical cancer. Prognostic factors and comptications
5. Lymphovascular space involvement in cervical cancer: An independent risk
6. Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study
7. Recent trends in cervix uteri cancer
8. Postoperative simultane radiochemotherapie verbessert überleben bei patientinnen mit zervixkarzinom
9. Keine verbesserung der therapieergebnisse durch eine neoadjuvante chemotherapie beim zervixkarzinom im vergteich zu einer alleinigen bestrahtung
10. Prognostic factors in patients with with tocalty advanced cervical cancer treated with radical hysterectomy and adjuvant radiotherapy
11. Survival of European women with gynaecological tumours during the period 1978-1989
12. Stellenwert der primären Strahlentherapie plus regionaler Tiefenhyperthermie beim fortgeschrittenen Zervixkarzinom im Stadium FIGO IIb-IV
13. Prophylaxe der strahleninduzierten diarrhö durch smektit. Ergebnisse einer doppelblind randomisierten, plazebokontrollierten multicenterstudie
14. Histopathologische prognosefaktoren beim primär operativ therapierten zervixkarzinom
15. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma
16. Tumor size, depth of invasion, and grading of the invasive tumor front are the main prognostic factors in early squamous cell cervical carcinoma
17. Preoperative prognostic variables and the impact of postoperative adjuvant therapy on the outcomes of Stage IB or II cervical carcinoma patients with or without pelvic lymph node metastases: An analysis of 891 cases
18. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer
19. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix
20. Prognostic significance of cervical lesion size and pelvic node metastases in cervical carcinoma
21. Diagnosis of angiologic function in unilateral leg edema following combined treatment of cervix cancer
22. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer
23. Surgical pathologic factors that predict recurrence in stage IB and IIA cervical carcinoma patients with negative pelvic lymph nodes
24. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: A Gynecologic Oncology Group study
25. "Survival tree analysis" - Eine neue methode zur multivariaten bewertung von prognosefaktoren beira operablen zervixkarzinom
26. Adjuvant radiotherapy following radical hysterectomy for patients with early-stage cervical carcinoma (1984-1996)
27. A randomized trial of standard versus partially hyperfractionated radiation with or without concurrent 5-fluorouracil in locally advanced cervical cancer
28. Improved treatment for cervical cancer-concurrent chemotherapy and radiotherapy
29. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: A Gynecologic Oncology Group and Southwest Oncology Group study
30. Postoperative radiotherapy in early stage carcinoma of the uterine cervix: Treatment results and prognostic factors
31. The epidemiology of cervical cancer and its precursors
32. Histopathologic predictors of the behavior of surgically treated stage IB squamous cell carcinoma of the cervix. A Gynecologic Oncology Group study